Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

389 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
IRF4 Mediates the Oncogenic Effects of STAT3 in Anaplastic Large Cell Lymphomas.
Bandini C, Pupuleku A, Spaccarotella E, Pellegrino E, Wang R, Vitale N, Duval C, Cantarella D, Rinaldi A, Provero P, Di Cunto F, Medico E, Bertoni F, Inghirami G, Piva R. Bandini C, et al. Among authors: pellegrino e. Cancers (Basel). 2018 Jan 18;10(1):21. doi: 10.3390/cancers10010021. Cancers (Basel). 2018. PMID: 29346274 Free PMC article.
IDH2 inhibition enhances proteasome inhibitor responsiveness in hematological malignancies.
Bergaggio E, Riganti C, Garaffo G, Vitale N, Mereu E, Bandini C, Pellegrino E, Pullano V, Omedè P, Todoerti K, Cascione L, Audrito V, Riccio A, Rossi A, Bertoni F, Deaglio S, Neri A, Palumbo A, Piva R. Bergaggio E, et al. Among authors: pellegrino e. Blood. 2019 Jan 10;133(2):156-167. doi: 10.1182/blood-2018-05-850826. Epub 2018 Nov 19. Blood. 2019. PMID: 30455381 Free article.
The heterogeneous landscape of ALK negative ALCL.
Mereu E, Pellegrino E, Scarfò I, Inghirami G, Piva R. Mereu E, et al. Among authors: pellegrino e. Oncotarget. 2017 Mar 14;8(11):18525-18536. doi: 10.18632/oncotarget.14503. Oncotarget. 2017. PMID: 28061468 Free PMC article. Review.
ALK expression favorably impacts the prognosis of NRAS-mutated metastatic melanomas.
Osella-Abate S, Mereu E, Pellegrino E, Bergaggio E, Ribero S, Bertero L, Lisa F, Fierro MT, Giulio Papotti M, Piva R. Osella-Abate S, et al. Among authors: pellegrino e. Oncol Lett. 2018 Dec;16(6):7091-7096. doi: 10.3892/ol.2018.9560. Epub 2018 Oct 9. Oncol Lett. 2018. PMID: 30546443 Free PMC article.
Identification of a new subclass of ALK-negative ALCL expressing aberrant levels of ERBB4 transcripts.
Scarfò I, Pellegrino E, Mereu E, Kwee I, Agnelli L, Bergaggio E, Garaffo G, Vitale N, Caputo M, Machiorlatti R, Circosta P, Abate F, Barreca A, Novero D, Mathew S, Rinaldi A, Tiacci E, Serra S, Deaglio S, Neri A, Falini B, Rabadan R, Bertoni F, Inghirami G, Piva R; European T-Cell Lymphoma Study Group. Scarfò I, et al. Among authors: pellegrino e. Blood. 2016 Jan 14;127(2):221-32. doi: 10.1182/blood-2014-12-614503. Epub 2015 Oct 13. Blood. 2016. PMID: 26463425 Free article.
ALK-dependent control of hypoxia-inducible factors mediates tumor growth and metastasis.
Martinengo C, Poggio T, Menotti M, Scalzo MS, Mastini C, Ambrogio C, Pellegrino E, Riera L, Piva R, Ribatti D, Pastorino F, Perri P, Ponzoni M, Wang Q, Voena C, Chiarle R. Martinengo C, et al. Among authors: pellegrino e. Cancer Res. 2014 Nov 1;74(21):6094-106. doi: 10.1158/0008-5472.CAN-14-0268. Epub 2014 Sep 5. Cancer Res. 2014. PMID: 25193384
389 results